Dr. Gmuca seeks to enhance the care of children with chronic musculoskeletal pain. Her current research addresses amplified musculoskeletal pain syndrome, which is a major public health issue because of its high prevalence, related socioeconomic burden, and associated risk of opioid exposure. Dr. Gmuca’s work aims to identify innovative strategies to improve long-term treatment outcomes for this patient population.
Dr. Bhatnagar's research aims to further the understanding of the neural basis of individual differences in response to stressful experiences. This includes identifying neural substrates that produce resiliency or vulnerability to the effects of stress and determining treatments to mitigate vulnerability and to promote resiliency through both preclinical and translational studies.
Dr. Hocking’s research aims to better understand the neurodevelopmental consequences of having survived childhood cancer or having neurofibromatosis type 1, to identify those who are most at risk for poor outcomes, and to intervene in some way in order to improve quality of life.
Dr. Barakat's research is focused on examining risk-and-resilience models to characterize disease management and health-related quality of life of children with chronic health conditions and their families. Another focus of investigation is translation of these models into evidence-based assessment (family psychosocial risk screening) as well as family-based, mHealth interventions to improve disease management and to support medical decision-making for youth with cancer and their families.
Dr. Ginsburg’s research focuses on facilitating youth to develop their own solutions to social problems and to teach clinicians how to better serve them. His current focus is on translating the best of what is known from research and practice into practical approaches parents, professionals, and communities can use to build resilience.
The Anderson Laboratory investigates the molecular and cellular mechanisms governing the development of the mammalian forebrain in relation to neuropsychiatric disease. The lab has a particular research interest on the fate determination of key subclasses of cortical inhibitory interneurons.
Through clinical and translational research, the Center for Amplified Musculoskeletal Pain Syndrome (CAMPS) research lab seeks to advance understanding of successful treatments for pediatric amplified musculoskeletal pain syndrome, with the overall goal of improving patients' and families' lives.
Conducting hospital- and community-based research to reduce exposure to and impact of violence among children and families, and designing innovative, evidence-based programs and initiatives that are implemented across clinical, school, and neighborhood settings.
The mission of the Stress Neurobiology Research Program is to further the understanding of the neural basis of individual differences in response to stressful experiences. This includes identifying neural substrates that produce resiliency or vulnerability to the effects of stress and determining treatments to mitigate vulnerability and to promote resiliency through both preclinical and translational studies.